Main description:

This book provides a comprehensive description of the global pharmaceutical industry along with its many public policy issues, both international and specific to the U.S. It presents basic economic analytical and empirical models useful for analyzing various aspects of pharmaceutical markets and drug policies. Coverage includes competition and market structure, the drug development process, pricing strategy, and post-marketing surveillance.

Feature:

A potential graduate textbook in the growing field of pharmaceutical economics and drug policy

Accessible to readers with minimal previous exposure to the discipline

The product of a truly interdisciplinary team of scholars (pharmacist and economist)

Includes original (not-elsewhere-published) research by the authors

Contents:

Preface.- Introduction.- Pharmaceutical Industry Overview.- Pharmaceutical Research and Development.- Pharmaceutical Production.- Pharmaceutical Marketing and Distribution.- Pharmacy Benefit Management.- Patients, Physicians, Pharmacists, and Insurers.- Drug Utilization Patterns.- Demand and Utility Theory for Medications.- Elasticity of Demand for Medications.- Definition of Drug Prices.- Characteristics of Market Competition.- Brand-Name and Generic Drugs.- Analysis of Pricing Strategies.- New Drug Approval.- Drug Information.- Patent Policy.- Antitrust Law, Mergers and Acquisitions, and Price Discrimination.- Drug Utilization Review and Cost-Containment Strategies.- Dietary Supplements and Alternative Medicines.- Post-Marketing Drug Surveillance and Drug Safety.- Pharmacoeconomic Evaluations for Formulary Decisions.